Author(s): Kingston R, Elizabeth Mathew, Shivakumar Swamy


DOI: Not Available

Address: Kingston R*, Elizabeth Mathew and Shivakumar Swamy
Mallige college of Pharmacy, Chikkabanavara , Bangalore-90, India.
*Corresponding Author

Published In:   Volume - 3,      Issue - 1,     Year - 2010

The antipsychotics have an elegant role in treating the schizophrenic patients,. Along with the non-pharmacological treatment .The success rates with newly diagnosed patients were better when drugs are used to reduce the risk of developing chronic conditions. The aim of this study is to assess the efficacy of olanzapine and risperidone among patients with schizophrenia. An assessment was made in newly diagnosed patients with schizophrenia to study the effect of olanzapine and risperidone prescribed to them and their personality changes. The study was conducted for 100 patients over a period of 6 months. Patients were divided into two groups and treated with olanzapine and risperidone . There was a significant difference in both the therapy, with the mean differences in both the groups. Statistically significantly greater proportion of the olanzapine-treated than risperidone-treated patients maintained their response. Both the drugs prescribed significantly improved the health condition of schizpohrenic patients. In individual drug therapy olanzapine is considered as the drug that has more efficacies with respect to the mean values. Though the personality change of the patients shows significant improvement, it can be improved much more through patient awareness programs and patient education.

Cite this article:
Kingston R, Elizabeth Mathew, Shivakumar Swamy. Assessment of Effect of Olanzapine Vs Risperidone among Patients with Schizophrenia In Terms of Personality Changes. Research J. Pharm. and Tech. 3(1): Jan.-Mar. 2010; Page 224-226.

Kingston R, Elizabeth Mathew, Shivakumar Swamy. Assessment of Effect of Olanzapine Vs Risperidone among Patients with Schizophrenia In Terms of Personality Changes. Research J. Pharm. and Tech. 3(1): Jan.-Mar. 2010; Page 224-226.   Available on:


1.        Lloyd G.G, Sharpe M. C, Medical psychiatry, Davidson’s Principles and Practice of Medicine, 19th edition, Churchill Livingstone, 2002; 245-247.

2.        Garyson S. Norquist and ­Darrel A. Regier, The Epidemiology of Psychiatric Disorders and the De Facto Mental Health Care System, Annual Review of Medicine, 1996; 47: 473-479.

3.        Victor.I. Reus Psychiatric Disorders, In: Eugene Braunwald, Anthony. S.Fauci, Dennis L. Kaspar, Stephen. L.Hauser, Dan.L.Longo, J.Larry Jameson, Editors. Harrison’s Principles of Internal Medicine, 15th edition. New York: Mc Graw-Hill, 2001; 2542.

4.        Mark H. Beers and Robert Berkow, The Merck Manual of Diagnosis and therapy, 17th edition, Merck research Laboratories (USA), 1999; 1564.

5.        Adrienne Z. Ables, Otis L. Baughman, Antidepressants: Update on New Agents and Indications, Am Fam Physician, 2003; 67: 547-554

6.        Dahl AA, Grov EK, Moum T, Fossa SD, Anxiety Depression and Quality of Life in caregivers of patients with cancer in late palliative phase, Annals of Oncology, 2005; 16: 1185-1191

7.        Pathiyil Ravi Shankar, Samit Roy, Patterns of Prescription And Drug use in a Psychiatry outpatient Department in a teaching hospital in western Nepal, The Internet journal of Pharmacology, 2002;1-8.

8.        Donoghue, Timothy R. Hylan, Antidepressants use in the Clinical Practice Efficacy vs Effectiveness, 2001; 179: s9-s17.

9.        Dan J. Stein, Elisabeth Wreford Anderson, Malcolm Lader, Escitalopram versus Paroxetine for social anxiety disorder: Analysis of Efficacy for different symptom dimensions, European Neuropsychopharmacology, 2006; 16: 33-38.

10.     Jack M. Gorman, Justine M. Kent, Jeremy D. Coplan, Current and Emerging Therapeutics of Anxiety and Stress Disorders, American College of Neuropsychopharmacology, 2002; 5: 967-980.

11.     Brian C. Lund, Michael Flaum, Laura A. Adam, Paul J. Perry, Psychiatric Prescribing Trends and Practices in Iowa’s Prisons, Psychiatric services, 2002; 53: 1023-1024.

12.     Jain-ping Chen, Charles Barron, Keh-Ming Lin, Henry Chung, Prescribing medication for Asians with mental disorder, west J med, 176; 2002: 271-275

13.     Helena S. Johnson, Heidi M. Inderbitzen-Nolan, Ann M. Schapman, A comparison between socially anxious and depressive symptomatology in youth: a focus on perceived family environment, Anxiety Disorders, 2005; 19: 423-442.

14.     Niclo Csacaleda, Jean-Philip Boulenger, Pharmacologic Treatment Effective in both Generalized Anxiety Disorder and Major Depressive Disorder: Clinical and Theoretical implications, Can J Psychiatry, 1998; 43: 722-730

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available